Biomea Fusion, Inc. (BMEA)
1.49
+0.05
(+3.47%)
USD |
NASDAQ |
Sep 24, 16:00
1.485
0.00 (0.00%)
After-Hours: 19:59
Biomea Fusion Market Cap : 108.00M for Sept. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 24, 2026 | 108.00M |
| September 23, 2026 | 104.38M |
| September 22, 2026 | 123.22M |
| September 21, 2026 | 123.95M |
| September 18, 2026 | 132.65M |
| September 17, 2026 | 129.75M |
| September 16, 2026 | 126.12M |
| September 15, 2026 | 130.47M |
| September 14, 2026 | 129.02M |
| September 11, 2026 | 126.12M |
| September 10, 2026 | 123.22M |
| September 09, 2026 | 133.73M |
| September 08, 2026 | 139.89M |
| September 04, 2026 | 147.14M |
| September 03, 2026 | 138.44M |
| September 02, 2026 | 140.26M |
| September 01, 2026 | 130.47M |
| August 31, 2026 | 121.77M |
| August 28, 2026 | 125.40M |
| August 27, 2026 | 121.77M |
| August 26, 2026 | 123.95M |
| August 25, 2026 | 125.40M |
| August 24, 2026 | 115.25M |
| August 21, 2026 | 99.30M |
| August 20, 2026 | 98.58M |
| Date | Value |
|---|---|
| August 19, 2026 | 100.75M |
| August 18, 2026 | 97.85M |
| August 17, 2026 | 97.85M |
| August 14, 2026 | 95.68M |
| August 13, 2026 | 92.78M |
| August 12, 2026 | 92.78M |
| August 11, 2026 | 93.50M |
| August 10, 2026 | 92.05M |
| August 07, 2026 | 91.33M |
| August 06, 2026 | 90.60M |
| August 05, 2026 | 91.33M |
| August 04, 2026 | 89.16M |
| August 03, 2026 | 86.98M |
| July 31, 2026 | 84.59M |
| July 30, 2026 | 88.21M |
| July 29, 2026 | 88.21M |
| July 28, 2026 | 90.37M |
| July 27, 2026 | 91.10M |
| July 24, 2026 | 90.37M |
| July 23, 2026 | 91.10M |
| July 22, 2026 | 93.27M |
| July 21, 2026 | 96.16M |
| July 20, 2026 | 94.71M |
| July 17, 2026 | 92.54M |
| July 16, 2026 | 91.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 392.15M |
| ACADIA Pharmaceuticals, Inc. | 3.818B |
| Alnylam Pharmaceuticals, Inc. | 33.38B |
| Anika Therapeutics, Inc. | 270.74M |
| Savara, Inc. | 1.041B |
Market Cap Related Metrics
| Price to Book Value | 8.899 |
| Price | 1.49 |
| Earnings Yield | -33.36% |